For diabetes patients, practical recommendations would be:
Start moderate-intensity statin therapy if:
Young, age 20-39, with microvascular complications or long-standing DM.
Older, age 40-75, without major risk factors.
Start high-intensity statin ± ezetimibe if the following factors are present with the goal of reducing LDLc ≥50%:
Multiple risk factors
ASCVD 10YR ≥20%
For adults >75, clinician-patient discussion is needed if statin were to be started or continued.